Aileron Therapeutics (ALRN) Announces Enrollment Expansion for Upcoming Phase 1b Clinical Trial of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cance
Go back to Aileron Therapeutics (ALRN) Announces Enrollment Expansion for Upcoming Phase 1b Clinical Trial of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cance| American Learning Corp (NASDAQ: ALRN) | Delayed: 5.05 +0.05 (1.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.00 | 52 Week High | $0.63 | |||
| Open | $5.07 | 52 Week Low | $0.07 | |||
| Day High | $5.10 | P/E | N/A | |||
| Day Low | $5.00 | EPS | $-0.13 | |||
| Volume | 27,493 | |||||
